|
Sections |
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents
Opportunities in Nutritional Management
Executive summary 10
Nutritional management: a growth area 10
Disease and patient targets 11
Key product and ingredient developments 12
Marketing issues and strategy 13
Chapter 1 Nutritional managem | 0 | 1 |
| Table of Contents | 0 | 1 |
| Opportunities in Nutritional Management | 0 | 1 |
| Executive summary 10 | 0 | 1 |
| Nutritional management: a growth area 10 | 0 | 1 |
| Disease and patient targets 11 | 0 | 1 |
| Key product and ingredient developments 12 | 0 | 1 |
| Marketing issues and strategy 13 | 0 | 1 |
| Chapter 1 Nutritional management: a growth area 16 | 0 | 1 |
| Summary 16 | 0 | 1 |
| Introduction 17 | 0 | 1 |
| A note about this report 17 | 0 | 1 |
| Nutrition’s increasingly accepted role in managing disease 17 | 0 | 1 |
| Where does “functional foods†end “nutritional management†start? 18 | 0 | 1 |
| Opportunities exist for both food and clinical nutrition companies 19 | 0 | 1 |
| Defining nutritional management 21 | 0 | 1 |
| A growing nutritional management audience 25 | 0 | 1 |
| Prevalence rates for key disease areas are increasing 25 | 0 | 1 |
| Government and healthcare policies also encourage a greater focus on nutrition 26 | 0 | 1 |
| Attractive outcomes will promote future growth 27 | 0 | 1 |
| Marketing approaches will need updating 29 | 0 | 1 |
| Food companies will need to operate differently 29 | 0 | 1 |
| Developing expertise in clinical trials will be crucial 30 | 0 | 1 |
| Top-down marketing approaches and influencing KOLs is necessary 30 | 0 | 1 |
| Healthcare marketing expertise will be required 31 | 0 | 1 |
| Building new sales channels is likely to be a complicated task 31 | 0 | 1 |
| Accounting for channel complexities 32 | 0 | 1 |
| Future Outlook 33 | 0 | 1 |
| Chapter 2 Disease and patient targets 36 | 0 | 1 |
| Summary 36 | 0 | 1 |
| Disease and therapy selection criteria 36 | 0 | 1 |
| Disease and therapy areas 37 | 0 | 1 |
| Market potential 38 | 0 | 1 |
| A note on modeling techniques used 38 | 0 | 1 |
| Further analysis potential 40 | 0 | 1 |
| Overall prevalence rates and sufferer numbers 40 | 0 | 1 |
| Hypertension offers the largest consumer audience to target 40 | 0 | 1 |
| CVD is the second largest disease area by the number of sufferers 41 | 0 | 1 |
| Of the other higher growth areas osteoporosis has significantly more sufferers 41 | 0 | 1 |
| In the other low growth areas, three diseases have significant population numbers 41 | 0 | 1 |
| France: prevalence rates and sufferer numbers 43 | 0 | 1 |
| Germany: prevalence rates and sufferer numbers 44 | 0 | 1 |
| Italy: prevalence rates and sufferer numbers 45 | 0 | 1 |
| The Netherlands: prevalence rates and sufferer numbers 46 | 0 | 1 |
| Spain: prevalence rates and sufferer numbers 47 | 0 | 1 |
| Sweden: prevalence rates and sufferer numbers 48 | 0 | 1 |
| UK: prevalence rates and sufferer numbers 49 | 0 | 1 |
| US: prevalence rates and sufferer numbers 50 | 0 | 1 |
| Conclusions 51 | 0 | 1 |
| Chapter 3 Key product and ingredient developments 54 | 0 | 1 |
| Summary 54 | 0 | 1 |
| Introduction 54 | 0 | 1 |
| Research into the area of nutritional management is in its early days 54 | 0 | 1 |
| A note on the diseases covered 56 | 0 | 1 |
| Nutritional intervention in Crohn’s disease 57 | 0 | 1 |
| Latest research on nutrition on Crohn’s disease 57 | 0 | 1 |
| The effects of exclusion diets on Crohn’s disease 57 | 0 | 1 |
| A role for antioxidants managing Crohn’s? 58 | 0 | 1 |
| A need to overcome malnutrition associated with Crohn’s 58 | 0 | 1 |
| Potential product opportunities in Crohn’s 59 | 0 | 1 |
| Nutritional intervention in diabetes 59 | 0 | 1 |
| Latest research on nutrition in diabetes 59 | 0 | 1 |
| Effects of dried sweetened cranberries (with added fiber) on diabetes 59 | 0 | 1 |
| Effects of safflower oil and conjugated linoleic acid on diabetes 60 | 0 | 1 |
| Effects of antioxidants in black tea on diabetes 60 | 0 | 1 |
| Potential product opportunities in diabetes 61 | 0 | 1 |
| Nutritional intervention in food allergies 62 | 0 | 1 |
| Latest research on nutrition on food allergies 62 | 0 | 1 |
| Effects of synbiotics on food allergies (non-human study) 62 | 0 | 1 |
| Nutritional intervention in heart disease/CVD 62 | 0 | 1 |
| Latest research on nutrition on heart disease/CVD 62 | 0 | 1 |
| Contrary to some recent research, vitamin supplementation may help 62 | 0 | 1 |
| Potential product opportunities in heart disease/CVD 63 | 0 | 1 |
| Nutritional intervention in HIV/AIDS 63 | 0 | 1 |
| Latest research on nutrition on HIV/AIDS 63 | 0 | 1 |
| Effects of beta-carotene and vitamin A on HIV/AIDS 64 | 0 | 1 |
| Effects of zinc on HIV/AIDS 64 | 0 | 1 |
| Effects of selenium on HIV/AIDS 65 | 0 | 1 |
| Effects of probiotics on HIV/AIDS 65 | 0 | 1 |
| Potential product opportunities in HIV/AIDS 66 | 0 | 1 |
| Nutritional intervention in hypertension 66 | 0 | 1 |
| Latest research on nutrition on hypertension 66 | 0 | 1 |
| Effects of wholegrains, especially bran, on hypertension 66 | 0 | 1 |
| Effects of flavonoids on hypertension (non-human study) 67 | 0 | 1 |
| Potential product opportunities in hypertension 68 | 0 | 1 |
| Nutritional intervention in IBS 68 | 0 | 1 |
| Latest research on nutrition on IBS 68 | 0 | 1 |
| Effects of synbiotics on IBS 68 | 0 | 1 |
| Nutritional intervention in malnutrition 69 | 0 | 1 |
| Latest research on nutrition on malnutrition 69 | 0 | 1 |
| Malnutrition is a major problem and one that is beginning to be tackled 69 | 0 | 1 |
| Effects of combined testosterone and nutritional supplement on malnutrition 70 | 0 | 1 |
| Potential product opportunities in malnutrition 70 | 0 | 1 |
| Nutritional intervention in osteoporosis 71 | 0 | 1 |
| Latest research on nutrition on osteoporosis 71 | 0 | 1 |
| Effects of vitamin D and calcium on osteoporosis 71 | 0 | 1 |
| Is vitamin D more important than calcium? 71 | 0 | 1 |
| Effects of dietary versus supplemental calcium on osteoporosis 72 | 0 | 1 |
| Effects of carotenoids on osteoporosis 73 | 0 | 1 |
| Effects of vegetarian diets on bone density 73 | 0 | 1 |
| Potential product opportunities in osteoporosis 74 | 0 | 1 |
| Nutritional intervention in wound healing 75 | 0 | 1 |
| Latest research on nutrition on wound healing 75 | 0 | 1 |
| Poor nutritional status can delay the healing process 75 | 0 | 1 |
| Nutrients required for wound healing and their roles 75 | 0 | 1 |
| Potential product opportunities in wound healing 77 | 0 | 1 |
| Will competition come from retail products? 77 | 0 | 1 |
| Could functional foods encroach on nutritional management? 77 | 0 | 1 |
| Are any functional foods currently targeting this area? 78 | 0 | 1 |
| Functional foods are not currently targeting nutritional management 78 | 0 | 1 |
| But some products might be suitable for targeting nutritional management 80 | 0 | 1 |
| Might regulation actually encourage competition? 81 | 0 | 1 |
| In the future functional foods will have better substantiated claims 81 | 0 | 1 |
| Conclusions 82 | 0 | 1 |
| Chapter 4 Marketing issues and strategy 86 | 0 | 1 |
| Summary 86 | 0 | 1 |
| Introduction 87 | 0 | 1 |
| A need to establish the Nutritional Management space 87 | 0 | 1 |
| Top-down marketing strategies 88 | 0 | 1 |
| Influencing the key opinion leaders is crucial 88 | 0 | 1 |
| Who are the KOLs? 89 | 0 | 1 |
| Marketing should be aligned with a top-down approach 90 | 0 | 1 |
| Targeting KOLs means undertaking pharmaceutical style research 90 | 0 | 1 |
| Consumer perceptions and needs 91 | 0 | 1 |
| Consumers’ needs are often overlooked 91 | 0 | 1 |
| Patients’ needs are similar to everyday consumers’ 91 | 0 | 1 |
| Better tasting products can improve patient outcomes 92 | 0 | 1 |
| Snacking may actually be beneficial for many hospital patients 92 | 0 | 1 |
| Aligning propositions with consumer needs 93 | 0 | 1 |
| A greater focus on sufferers’ needs is required 93
Great scope for further research into nutritional management preferences exists 94
Branded food items may well have a role to play 94
Channel issues 95
Education will be key in targeting hospital channel | 0 | 1 |
